CR3 Keyless Split Sample Cup Nortriptyline-Buprenorphine

Radioimmunoassay, Tricyclic Antidepressant Drugs

Guangzhou Wondfo Biotech Co., Ltd.

The following data is part of a premarket notification filed by Guangzhou Wondfo Biotech Co., Ltd. with the FDA for Cr3 Keyless Split Sample Cup Nortriptyline-buprenorphine.

Pre-market Notification Details

Device IDK142609
510k NumberK142609
Device Name:CR3 Keyless Split Sample Cup Nortriptyline-Buprenorphine
ClassificationRadioimmunoassay, Tricyclic Antidepressant Drugs
Applicant Guangzhou Wondfo Biotech Co., Ltd. Wondfo Scientech Park, South China Univ. Of Technology Guangzhou,  CN
ContactBen Chen
CorrespondentJoe Shia
LSI INTERNATIONAL INC. 504 East Diamond Ave. Suite F Giathersburg,  MD  20878
Product CodeLFG  
CFR Regulation Number862.3910 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-09-16
Decision Date2014-12-18
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.